nhs research scotland collaborates with vital …...with vital therapies to accelerate clinical...
TRANSCRIPT
www.nrs.org.uk @NHSResearchScot
Supporting commercial research in NHS Scotland
NHS Research Scotland collaborates with Vital Therapies to accelerate clinical trials of ELADA new treatment designed to improve survival in patients with liver failure by providing extracorporeal hepatic support continuously for up to five days.
“This is an important study. We believe that use of ELAD allows time for the patient’s native liver to recover from an acute decompensation, stabilize, and then potentially regenerate, or to maintain the patient until liver transplantation can occur.
The connected, collaborative and streamlined approach in Scotland has enabled rapid start-up of this study at 2 centres of excellence within a 4 month period that included the Christmas holidays. The sites have proven pedigree in this type of trial having contributed to the UK-wide STOPAH trial. The Vital Therapies study ultimately hopes to translate ELAD into a possible new treatment option for liver failure patients who have a high mortality risk.”
Andrew Henry, VP Clinical Operations, VITAL THERAPIES Inc
Vital Therapies, Inc. is a biotherapeutic company developing ELAD®, an extracorporeal human hepatic cell-based liver treatment.
Further information To discuss placing a trial in Scotland contact Steven Burke, Industry Liaison Manager
[email protected] / +44 141 951 5508 or visit www.nrs.org.uk/industry
www.nrs.org.uk @NHSResearchScot
“Scotland is a world leading location for clinical research as evidenced by its well connected life sciences sector, strong research base, talent pool and streamlined, joined up approach to supporting companies.”
Julia Brown, Senior Director, Healthcare Life and Chemical Sciences, Scottish Enterprise.
Fiona AlexanderInternational Senior Executive - Tourism Scottish Development International T +44 (0) 141 951 3040 M +44 (0) 7775 823 935 E [email protected] www.sdi.co.uk
150 Broomielaw Atlantic Quay Glasgow G2 8LU Scotland UK
6.0 SE-Gov Translated_Fiona Alexander_G2 8LU.indd 1 12/01/2017 14:34
An efficient and responsive infrastructure, enabled this complex study, with intensive resource requirement, to be set up within 4 months from initial contact
• NRS feasibility service identified two sites in Glasgow and Dundee
• Rapid review of study completed via NRS Permissions Co-ordinating Centre and negotiation of national standard contract and budget
• Hepatology Clinical Lead provided national oversight, advice and co-ordinated approach to discussions
“Collaboration and early engagement are critical in complex trials such as VTL-308 and I’ve been delighted to bring this trial to Scotland offering opportunities for patients to access innovative new treatments in liver disease”
Professor John Dillon, NRS Hepatology Clinical Lead
NHS Research Scotland (NRS) is a partnership of Scottish NHS Boards and the Chief Scientist Office of Scottish Government. Registered Number: GB 236303. Registered address: The Golden Jubilee National Hospital, Fourth Floor East, Agamemnon St, Clydebank, G81 4DYPublished by NHS Research Scotland. All rights reserved. Material contained in this publication may not be reproduced in whole or part without prior permission of NHS Research Scotland (or other copyright owners). Whilst every effort is made to ensure that the information given here is accurate, no legal responsibility is accepted for any errors, omissions or misleading statements.